U01.01.062 Fragile X syndrome

 

Learning Objectives

  • Identify the genetic mechanism of Fragile X, including trinucleotide repeats and methylation.
  • Distinguish between inherited and genetic causes of intellectual disability.
  • Recognize the clinical triad of macroorchidism, long face, and large ears.
  • Understand the difference between premutation and full mutation phenotypes.

1. Genetics & Pathophysiology

Fragile X is an atypical X-linked disorder characterized by the expansion of a trinucleotide repeat in the FMR1 gene.

  • The Repeat: (CGG)n expansion occurs during oogenesis.
  • The Mechanism: Expansion leads to hypermethylation of cytosine residues, which effectively “silences” the gene (decreased expression).
  • Impact: Fragile X is the most common inherited cause of intellectual disability. (Note: Down syndrome is the most common genetic cause, but it is usually sporadic.)

Activity


2. Clinical Manifestations (Full Mutation)

The “Full Mutation” involves >200 repeats. Physical findings are most prominent after puberty.

Category Key Clinical Findings
Physical Postpubertal macroorchidism (large testes), long face with large jaw, large everted ears.
Neuro-Psych Intellectual disability, autism, self-mutilation.
Connective Tissue Mitral valve prolapse (MVP), hypermobile joints.

3. The Premutation (50–200 repeats)

Individuals with the premutation do not show the full syndrome but may present with distinct clinical issues:

  • Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): Late-onset progressive neurological decline.
  • Primary Ovarian Insufficiency: Early menopause in females.

 


Activity